Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Amélie Bigorgne"'
Autor:
Delphine Bredel, Edi Tihic, Séverine Mouraud, François-Xavier Danlos, Sandrine Susini, Marine Aglave, Alexia Alfaro, Chifaou Mohamed-Djalim, Mathieu Rouanne, Héloise Halse, Amélie Bigorgne, Lambros Tselikas, Stéphane Dalle, Dana M. Hartl, Eric Baudin, Catherine Guettier, Eric Vibert, Olivier Rosmorduc, Caroline Robert, Sophie Ferlicot, Bastien Parier, Laurence Albiges, Vincent Thomas de Montpreville, Benjamin Besse, Olaf Mercier, Caroline Even, Ingrid Breuskin, Marion Classe, Camélia Radulescu, Thierry Lebret, Patricia Pautier, Sébastien Gouy, Jean-Yves Scoazec, Laurence Zitvogel, Aurélien Marabelle, Mélodie Bonvalet
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-17 (2023)
Abstract Background In addition to anti-PD(L)1, anti-CTLA-4 and anti-LAG-3, novel immune checkpoint proteins (ICP)-targeted antibodies have recently failed to demonstrate significant efficacy in clinical trials. In these trials, patients were enrolle
Externí odkaz:
https://doaj.org/article/52536a48956445e0b8dee1144f166f82
Autor:
Mathieu Rouanne, Julien Adam, Camélia Radulescu, Diane Letourneur, Delphine Bredel, Séverine Mouraud, Anne-Gaëlle Goubet, Marion Leduc, Noah Chen, Tuan Zea Tan, Nicolas Signolle, Amélie Bigorgne, Michael Dussiot, Lambros Tselikas, Sandrine Susini, François-Xavier Danlos, Anna K. Schneider, Roman Chabanon, Sophie Vacher, Ivan Bièche, Thierry Lebret, Yves Allory, Jean-Charles Soria, Nicholas Arpaia, Guido Kroemer, Oliver Kepp, Jean Paul Thiery, Laurence Zitvogel, Aurélien Marabelle
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 12 (2022)
Patients with high-risk, nonmuscle-invasive bladder cancer (NMIBC) frequently relapse after standard intravesical bacillus Calmette-Guérin (BCG) therapy and may have a dismal outcome. The mechanisms of resistance to such immunotherapy remain poorly
Externí odkaz:
https://doaj.org/article/d3133523389b44ef89a70120d1393a04
Autor:
Tiphaine Lambert, Cedric Pobel, Léo Colmet-Daage, Amélie Bigorgne, Brice RaubyY, Nicolas Sanchez-Escobar Aladro, Lucile Ter-MinassianN, Marie Kerisit, Aurélien Marabelle, Benjamin Besse, Antoine Hollebecque, Stéphane Champiat, Christophe Massard, Daphné Morel, Loic Velringue, Jean-Yves Scoazec
Publikováno v:
Cancer Treatment and Research Communications, Vol 32, Iss , Pp 100611- (2022)
PD-L1 and tumor-infiltrating lymphocytes play a key role in the immune escape of cancer, although their prognostic value remains unknown in patients with refractory solid cancer compared to other known prognostic estimation methods. In this ancillary
Externí odkaz:
https://doaj.org/article/95ce7b4936574ff9942662be50f5b474
Autor:
Tina B.S. Miholjcic, Heloise Halse, Mélodie Bonvalet, Amélie Bigorgne, Mathieu Rouanne, Laurent Dercle, Vishnu Shankar, Aurélien Marabelle
Publikováno v:
European Journal of Cancer. 181:166-178
Autor:
Laurence Zitvogel, Vincent Ribrag, Aurélien Marabelle, Julien Lazarovici, Julien Adam, Lambros Tselikas, Veronique Minard, David Ghez, Jean-Marie Michot, Severine Mouraud, Alina Danu, Amélie Bigorgne, Charlotte Rigaud, Camille Bigenwald, Peggy Dartigues
Publikováno v:
Cancers, Vol 13, Iss 5487, p 5487 (2021)
Cancers
Volume 13
Issue 21
Cancers
Volume 13
Issue 21
Background: Resistance to anti-PD-1 remains a considerable clinical challenge for the treatment of patients with classical Hodgkin lymphoma (cHL), and mechanisms of anti-PD-1 resistance remain unknown. This pilot study aims to investigate the tumor m
Autor:
John S Nemer, Romain-David Seban, Samy Ammari, Fatima-Zohra Mokrane, Yvonne M. Saenger, Grace G. Finkel, Randy Yeh, Eric Deutsch, Laurent Dercle, Lawrence H. Schwartz, Luke W. Barker, Caroline Robert, Robyn D. Gartrell, Amélie Bigorgne, Antoine Moya-Plana, Aurélien Marabelle
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 46:2298-2310
An imaging-based stratification tool is needed to identify melanoma patients who will benefit from anti Programmed Death-1 antibody (anti-PD1). We aimed at identifying biomarkers for survival and response evaluated in lymphoid tissue metabolism in sp
Autor:
Mathieu Rouanne, Julien Adam, Camélia Radulescu, Diane Letourneur, Delphine Bredel, Séverine Mouraud, Anne-Gaëlle Goubet, Marion Leduc, Noah Chen, Tuan Zea Tan, Nicolas Signolle, Amélie Bigorgne, Michael Dussiot, Lambros Tselikas, Sandrine Susini, François-Xavier Danlos, Anna K. Schneider, Roman Chabanon, Sophie Vacher, Ivan Bièche, Thierry Lebret, Yves Allory, Jean-Charles Soria, Nicholas Arpaia, Guido Kroemer, Oliver Kepp, Jean Paul Thiery, Laurence Zitvogel, Aurélien Marabelle
Publikováno v:
Journal of Clinical Investigation
Journal of Clinical Investigation, 2022, 132 (12), pp.e145666. ⟨10.1172/JCI145666⟩
Journal of Clinical Investigation, 2022, 132 (12), pp.e145666. ⟨10.1172/JCI145666⟩
International audience; Patients with high-risk, nonmuscle-invasive bladder cancer (NMIBC) frequently relapse after standard intravesical bacillus Calmette-Guérin (BCG) therapy and may have a dismal outcome. The mechanisms of resistance to such immu
Autor:
Michael Dussiot, Sophie Vacher, Severine Mouraud, Yves Allory, Aurélien Marabelle, Lambros Tselikas, Roman M. Chabanon, Diane Letourneur, Anne-Gaëlle Goubet, Anna K. Schneider, Jean-Charles Soria, Mathieu Rouanne, Sandrine Susini, Ivan Bièche, François-Xavier Danlos, Jean Paul Thiery, Amélie Bigorgne, Delphine Bredel, Camelia Radulescu, Julien Adam, Laurence Zitvogel, Tuan Zea Tan, Nicolas Signolle, Thierry Lebret
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPatients with high-risk non muscle-invasive bladder cancer (NMIBC) frequently relapse after standard BCG immunotherapy and have a dismal outcome after progression to muscle-invasive bladder cancer (MIBC).1 2 The mechanisms of tumor resistan
Autor:
Jean Paul Thiery, Amélie Bigorgne, Michael Dussiot, Thierry Lebret, Delphine Bredel, Diane Letourneur, Lambros Tselikas, Laurence Zitvogel, Mathieu Rouanne, Ivan Bièche, Tuan Zea Tan, Jean-Charles Soria, Camelia Radulescu, Julien Adam, Severine Mouraud, Yves Allory, Roman M. Chabanon, Anna K. Schneider, Aurélien Marabelle, Sandrine Susini, François-Xavier Danlos, Nicolas Signolle, Sophie Vacher
Publikováno v:
Cancer Research. 81:66-66
Patients with high-risk non muscle-invasive bladder cancer (NMIBC) frequently relapse after standard BCG immunotherapy and have a dismal outcome after progression to muscle-invasive bladder cancer (MIBC). The mechanisms of tumor resistance to such im
Autor:
G. de Saint Basile, Nizar Mahlaoui, Amélie Bigorgne, Fernando E. Sepulveda, A Fischer, C. Leveau, Smail Hadj-Rabia, Roxane Lemoine, Stéphanie Leclerc-Mercier
Publikováno v:
British Journal of Dermatology. 175:1061-1064